Healthcare >> CEO Interviews >> October 22, 2001
JOHN R. DEPHILLIPO is Chairman, Chief Executive Officer and Founder of
GeneLink, Inc. He was educated at Temple University in Business
Administration, and was Chairman and CEO of Applied Safety, Inc. Since
1994, Mr. DePhillipo has been responsible for developing the initial
GeneLink 'DNA banking concept' and establishing GeneLink's DNA
Laboratory and Storage facility at the University of North Texas Health
Science Center in Forth Worth, Texas. This resulted in a long-term
contract between GeneLink_ and the University. He also began to broaden
GeneLink's business model by aggressively seeking new genomic technology
patents which included GeneLink's DNA Collection Kit'. In the late 1990s
he began pioneering the development of GeneLink's breakthrough genetic
profiling technologies (patents pending) for worldwide licensing. His
aggressive leadership style and marketing savvy have helped GeneLink
earn national and international recognition as a trusted resource for
confidential DNA banking and has positioned GeneLink as a leading
provider of genomic technologies. Profile
GeneLink, Inc.?
Mr. DePhillipo: The company was formed in 1994 in response to the
explosion of information being
